Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Shanghai HeartCare Medical Technology Corp Ltd
Revenue
Shanghai HeartCare Medical Technology Corp Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
|
Revenue
¥277.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Revenue
¥1.7B
|
CAGR 3-Years
51%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Revenue
¥7.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Revenue
¥37.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Revenue
¥5.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
12%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Revenue
¥11.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai HeartCare Medical Technology Corp Ltd
Glance View
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.
See Also
What is Shanghai HeartCare Medical Technology Corp Ltd's Revenue?
Revenue
277.9m
CNY
Based on the financial report for Dec 31, 2024, Shanghai HeartCare Medical Technology Corp Ltd's Revenue amounts to 277.9m CNY.
What is Shanghai HeartCare Medical Technology Corp Ltd's Revenue growth rate?
Revenue CAGR 3Y
46%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Shanghai HeartCare Medical Technology Corp Ltd have been 46% over the past three years .
You don't have any saved screeners yet